Genea Biocells

Human Stem Cell Model of Muscular Dystrophy (FSHD) – qPCR

Human Embryonic Stem Cells

Genea Biocells has developed the world’s largest and most varied private bank of ‘gold standard’ pluripotent human embryonic stem cells with more than 150 cell lines. Disease-specific cell lines as well as unaffected and sibling lines are available, in a variety of genetic backgrounds including variation in ethnic background, HLA and blood types.

Our hESC lines meet all internationally recognized requirements for stem cell research and were derived in full compliance with international ethical and regulatory guidelines – many of our lines have been registered at the NIH stem cell registry.

Each batch of cells undergoes strict quality control:

  • DNA fingerprinting
  • CGH karyotyping
  • Pluripotency marker expression by high-content analysis Pluritest `{`send link from article`}`
  • Mycoplasma and sterility testing
  • Viability and plating efficiency after thawing
  • Specific tests (where applicable) e.g. confirmation of CAG repeat length in Huntington’s disease cell lines

Scientists at non-profit organizations can purchase Genea Biocells cell lines for in vitro research purposes and non-commercial use based on a standard MTA. For-profit customers should contact us to discuss licensing options. Our cells are supplied as frozen stocks together with 100 ml of Genea Biocells M2 culture medium for optimal post-thaw viability. Cells can either be maintained in Genea Biocells M2 or adapted to other culture platforms.

Leave a Reply

Your email address will not be published. Required fields are marked *